Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 9

See more details

Referenced in 1 policy sources
Referenced in 10 patents
71 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118573

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.

J Zabner, B W Ramsey, D P Meeker, M L Aitken, R P Balfour, R L Gibson, J Launspach, R A Moscicki, S M Richards, and T A Standaert

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Zabner, J. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Ramsey, B. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Meeker, D. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Aitken, M. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Balfour, R. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Gibson, R. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Launspach, J. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Moscicki, R. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Richards, S. in: JCI | PubMed | Google Scholar

Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City, 52242, USA.

Find articles by Standaert, T. in: JCI | PubMed | Google Scholar

Published March 15, 1996 - More info

Published in Volume 97, Issue 6 on March 15, 1996
J Clin Invest. 1996;97(6):1504–1511. https://doi.org/10.1172/JCI118573.
© 1996 The American Society for Clinical Investigation
Published March 15, 1996 - Version history
View PDF
Abstract

Cystic fibrosis (CF) is a common autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator gene. Recombinant adenoviruses have shown promise as vectors for transfer of CF transmembrane conductance regulator cDNA to airway epithelia and correction of the Cl- transport defect. However, because adenovirus-mediated gene transfer is transient, use of adenovirus as a vector for treatment of CF would require repeated administration. Therefore, we evaluated repeat administration of an adenovirus vector to the nasal epithelium of patients with CF with five escalating doses of up to 10(10) infectious units. There were no detectable adverse affects. All subjects were initially seropositive but developed additional humoral immune responses. The vector partially corrected the defect in airway epithelial Cl- transport in some subjects, although there was variability between subjects and there was less correction with subsequent administration, perhaps because the immune response limited gene transfer. Future work must focus on vectors with increased efficiency and with the ability to evade host defenses.

Version history
  • Version 1 (March 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 9
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 10 patents
71 readers on Mendeley
See more details